Donald J. Webber

C. R. Bard, Inc. engages in designing, development, manufacturing, packaging, distribution, and sales of medical, surgical, diagnostic, and patient care devices. It sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Franklin Lakes, NJ.

EKOS Corp. povides ultrasound accelerated and fluid infusion catheters for diagnosis and therapy. The company was founded 1995 by Douglas R. Hansmann and Joseph E. Eichinger and is headquartered in Bothell, WA.

Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.

SynCardia Systems LLC engages in the manufacture of temporary total artificial heart. Its total artificial heart provides immediate, safe blood flow of up to 9.5 L/min through each ventricle. The company was founded by Marvin J. Slepian, Jack G. Copeland, and Richard G. Smith in 2001 and is headquartered in Tucson, AZ.

Bridge to Life Ltd. is a company that focuses on improving organ transplants by developing new preservation solutions and technologies. Bridge to Life is based in Northbrook, IL and has subsidiaries in Canada. The company is a leading supplier of preservation solutions worldwide and are currently enrolling patients in a study to evaluate the safety and effectiveness of the Vitasmart system. The company also has devices in development for lung and heart perfusion. The company was founded in 2005, and Donald J. Webber has been the CEO of the company since 2022.

OptiScan Biomedical Corp. develops and provides continuous monitoring systems for hospital intensive care units. The company offers OptiScanner 5000, a bedside blood monitoring platform that provides plasma-based, automated monitoring of patients’ glucose levels without the need for calibration, as well as uses a disposable cartridge containing the fluid pathway for sampling, storing, processing, and analyzing blood. The company was founded by James R. Braig and Daniel S. Goldberger in 1994 and is headquartered in Hayward, CA.